Latest news
Keros Therapeutics (NASDAQ:KROS) Raised to "Sell" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:44 GMTRenaissance Technologies LLC Sells 138,204 Shares of Keros Therapeutics, Inc. $KROS - MarketBeatMarketBeat · Fri, 07 Aug 2026 17:49:25 GMTAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 05:38:00 GMTKROS Q2 Earnings Miss as Revenues Fall to Zero, Pipeline in Focus - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 14:43:00 GMTKROS Maintained by Wells Fargo -- Price Target Lowered to $18.00 - GuruFocusGuruFocus · Tue, 04 Aug 2026 14:18:22 GMTH.C. Wainwright Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $20 - MoomooMoomoo · Tue, 04 Aug 2026 13:31:00 GMTKeros Therapeutics, Inc. Stock 12‑Month Price Target Cut to $20.33, Implies 101% Upside - TradingViewTradingView · Tue, 04 Aug 2026 13:20:05 GMTKeros Therapeutics (NASDAQ:KROS) Price Target Lowered to $23.00 at Leerink Partners - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:18:37 GMT